Moderna Betrays Africa, Says AHF
It raked in $30 billion in profit since 2021.
- It raked in $30 billion in profit since 2021.
- Now, it claims the mRNA factory in Kenya is no longer worth the investment because the African market for vaccines is not profitable enough.
- The only reason Moderna was able to achieve such astronomical profits in the first place was because it exploited publicly funded research and gained a stranglehold on the global supply of COVID-19 vaccines,” said AHF President Michael Weinstein.
- To learn more about AHF, please visit our website: www.aidshealth.org , find us on Facebook: www.facebook.com/aidshealth and follow us on Twitter: @aidshealthcare and Instagram: @aidshealthcare .